Conservative approach to severe ulcerative colitis

Digestive and Liver Disease

Volumn 36, Issue 1, 2004, Pages 4-6

  Fedorak, Richard N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHYLPREDNISOLONE; GLUCOCORTICOID;

BODY TEMPERATURE; CLINICAL TRIAL; COLON RESECTION; CONSERVATIVE TREATMENT; CORRELATION ANALYSIS; DEFECATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; HUMAN; HYDRATION; INTRAVENOUS ADMINISTRATION; LEUKOCYTE COUNT; MEDICAL DECISION MAKING; MORTALITY; NOTE; PRACTICE GUIDELINE; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; PULSE RATE; RETROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT FAILURE; ULCERATIVE COLITIS; FLUID THERAPY; METABOLISM; TREATMENT OUTCOME;

C-REACTIVE PROTEIN; COLITIS, ULCERATIVE; FLUID THERAPY; GLUCOCORTICOIDS; HUMANS; METHYLPREDNISOLONE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 2142766791     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2003.10.002     Document Type: Article

References (23)

1. Daperno M, Sostegni R, Scaglione N, Ercole E, Rigazio C, Rocca R, et al. Outcome of a conservative approach in severe ulcerative colitis. Dig Liver Dis 2004;36:21-8.
2. Chapman RW, Selby WS, Jewell DP. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut 1986;27:1210-2.
3. Travis SP, Farrant JM, Richetts C, Nolan DJ, Mortensen NM, Kettlewell MG, et al. Predicting an outcome in severe ulcerative colitis. Gut 1996;38:905-10.
4. Lindgren SC, Flood LM, Kilander AF. Early predictors of glucocorticoid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 1998;10:831-5.
5. Lennard-Jones JE, Ritchie JK, Hilder W, Spicer CC. Assessment of severity in colitis: a preliminary study. Gut 1975;16:579-84.
6. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J 1955;2:1041-8.
7. Seo M, Okada M, Yao T, Ueki M, Arima S, Okumura M. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1992;87:971-6.
8. Banks BM, Korelitz BI, Zetzel IL. The course of non-specific ulcerative colitis: review of twenty years experience and late results. Gastroenterology 1952;32:983-1012.
9. Edwards FC, Truelove SC. The course and prognosis of the ulcerative colitis. Gut 1963;4:299-315.
10. Elliott PR, Powell-Tuck J, Gillespie PE, Laidlow JM, Lennard-Jones JE, English J, et al. Prednisolone absorption in acute colitis. Gut 1980;21:49-51.
11. Berghouse LM, Elliott PR, Lennard-Jones JE, English J, Marks V. Plasma prednisolone levels during intravenous therapy in acute colitis. Gut 1982;23:980-3.
12. Marshall JK, Irvine EJ. Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Gut 1997;40:775-81.
13. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974;1067-70.
14. Truelove SC, Lee EG, Willoughby CP, Kettlewell MGW. Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 1978;1086-8.
15. Jarnerot G, Rolny P, Sandberg-Gertzen H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1985;89:1005-13.
16. Rosenberg W, Ireland A, Jewell DP. High-dose methylprednisolone in the treatment of active ulcerative colitis. J Clin Gastroenterol 1990;12:40-1.
17. Mantzaris GJ, Petraki K, Archavlis E, Amberiadis P, Kourtessas D, Chistidou A, et al. A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis. Scand J Gastroenterol 2001;36:971-4.
18. D'Haens G, Lemmens L, Geboes K, Vandeputte L, Van Acker F, Mortelmans L, et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 2001;120:1323-9.
19. Lichtiger S, Present DH, Kornbluth A, Gelernt L, Bauer J, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Eng J Med 1994;330:1841-5.
20. Hyde GM, Thillainayagam AV, Jewell DP. Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal? Eur J Gastroenterol Hepatol 1998;10:411-3.
21. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol 1999;94:1587-92.
22. Rowe FA, Walker JH, Karp LC, Vasiliauskas EA, Plevy SE, Targan SR. Factors predictive of response to cyclosporin treatment for severe, steroid resistant ulcerative colitis. Am J Gastroenterol 2000;95:2000-8.
23. Hogenauer C, Wenzl HH, Hinterleitner TA, Petritsch W. Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis. Aliment Pharmacol Ther 2003;18:415-23.